Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Portugal subsidises medical cannabis.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Portugal subsidises medical cannabis.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 25, 2022

Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card. Although a lot of research is being conducted on the subject, no conclusive medical data has been provided to the medical community. Can I Buy Medical Marijuana in Pennsylvania? Anxiety disorders.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Research published in 2016 revealed that 59% of a sample of patients who misused opioids were first exposed to them through a medical prescription. Expanded Qualifying Conditions.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

DECEMBER 9, 2019

Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon. Why so little research? Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

WeedAdvisor

APRIL 8, 2019

With this kind of accessibility, CBD’s popularity skyrocketed in all 50 states. Research is being done into several claims about CBD, specifically anxiety, depression and pain relief. But again, these are based on little data that is mostly anecdotal. The question is whether many of the reported benefits are true. The post U.S.

Food 40

Food CBD Research and Development Treatment 40

Cannabis Law Report

MAY 7, 2019

Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Liht’s ability to access private and public capital could be affected and or could not be available to support continuing operations. Veritas Pharma Inc. CTL“), is advancing the science behind medical cannabis.

Compliance 63

Compliance Compliance Research and Development Strains 63

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MYMD-1.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Drake is well-known as an inspiring and inclusive leader who is dedicated to the development of her teams and solely focused on organizational success for the benefit of patients. Julie Hoff to Vice President, Human Resources. Prior to joining Sesen Bio, Dr. McLin was Sr.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., Selling unapproved products with unsubstantiated therapeutic claims can put patients and consumers at risk.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JANUARY 27, 2020

The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. But what if a view develops suggesting that all this CBD could be causing health problems, not just resolving them?

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

SMPL

MAY 26, 2020

For years, he’d been determined to connect the nascent CBD research he heard about at symposiums abroad with the medical marijuana movement in California. This makes further research very difficult to do, and causes sick people in many states to be treated as criminals. San Francisco weekly. We were in communication for many years.”.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). hospital) or a company) and must be approved by a human research ethics committee (HREC).

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JUNE 12, 2022

When Prime Minister, Justin Trudeau, introduced The Cannabis Act, the goals of the act included protecting public health, ensuring that criminals no longer profited, and preventing youth from accessing the drug. Data like this is often perceived as another good motive to excuse cannabis related sentences, (particularly harsher convictions).

Research and Development 98

Research and Development Recreational Programs Cannabis 98

Healer

JANUARY 17, 2022

More recently, breeders have developed varieties of cannabis that lack the enzymes responsible for converting CBGA into the other cannabinoids, resulting in fully mature flowers dominant in CBGA and low in THC and other cannabinoids. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

More recently, breeders have developed varieties of cannabis that lack the enzymes responsible for converting CBGA into the other cannabinoids, resulting in fully mature flowers dominant in CBGA and low in THC and other cannabinoids. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

StrainConnect

FEBRUARY 8, 2019

If you’re here, it means you may be interested in CBD for yourself, a friend or a loved one, or perhaps you’re an industry professional conducting research. Consider us your home for CBD, hemp and cannabis research, education, and personalized product recommendations. Were here to help you make informed decisions.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

NOVEMBER 22, 2019

Medical cannabis users in Massachusetts are on track to regain access to vaping products starting Tuesday, November 12, after the Cannabis Control Commission did not uphold the Baker administration’s ban, though that permission could be short-lived amid ongoing legal challenges and potential future regulations from the commission.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. Yet, access to legal medicinal marijuana remains extremely limited. policy, and?could

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40